Literature DB >> 12060129

T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome.

Danièle Bensoussan1, Françoise Le Deist, Véronique Latger-Cannard, Marie José Grégoire, Odile Avinens, Pierre Feugier, Violaine Bourdon, Christine André-Botté, Claudine Schmitt, Philippe Jonveaux, Jean François Eliaou, Jean François Stoltz, Pierre Bordigoni.   

Abstract

Complete DiGeorge syndrome (cDGS) is a congenital disorder characterized by typical facies, thymic aplasia, susceptibility to infections, hypoparathyroidism and conotruncal cardiac defect. Fetal thymus or post-natal thymus tissue transplantations and human leucocyte antigen (HLA)-genoidentical bone marrow transplantations were followed in a few cases by immune reconstitution. More recently, a peripheral blood mononuclear cell transplantation (PBMCT) was performed with an HLA-genoidentical donor and followed by a partial T-cell engraftment and immune reconstitution. We report a boy with cDGS, without cardiac defect, who suffered recurrent severe infections. At the age of 4 years, he underwent PBMCT from his HLA-genoidentical sister. He received no conditioning regimen, but graft-versus-host disease (GVHD) prophylaxis was with oral cyclosporin A and mycophenolate mofetil. Toxicity was mild, with grade I acute GVHD. The patient is currently 2.5 years post-PBMCT with excellent clinical performances. Mixed chimaerism can only be observed on the T-cell population (50% donor T cells). T-lymphocyte count fluctuated (CD3 more than 400 x 10(6)/l at d 84 and CD4 more than 200 x 10(6)/l at d 46). Exclusive memory phenotype T cells and absence of new thymic emigrants suggest expansion of infused T cells. T-cell mitogen and tetanus antigen responses normalized a few months after transplantation. After immunizations, specific antibodies were produced. PBMCT from an HLA identical sibling could be an efficient treatment of immune deficiency in cDGS.

Entities:  

Mesh:

Year:  2002        PMID: 12060129     DOI: 10.1046/j.1365-2141.2002.03496.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly.

Authors:  Ales Janda; Petr Sedlacek; Manfred Hönig; Wilhelm Friedrich; Martin Champagne; Tadashi Matsumoto; Alain Fischer; Benedicte Neven; Audrey Contet; Danielle Bensoussan; Pierre Bordigoni; David Loeb; William Savage; Nada Jabado; Francisco A Bonilla; Mary A Slatter; E Graham Davies; Andrew R Gennery
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

2.  Immunologic reconstitution in 22q deletion (DiGeorge) syndrome.

Authors:  Sean A McGhee; Maria Garcia Lloret; E Richard Stiehm
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  Congenital T cell deficiency in a patient with CHARGE syndrome.

Authors:  Julie Hoover-Fong; William J Savage; Emily Lisi; Jerry Winkelstein; George H Thomas; Lies H Hoefsloot; David M Loeb
Journal:  J Pediatr       Date:  2009-01       Impact factor: 4.406

4.  Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection.

Authors:  Maria Chitty-Lopez; Carla Duff; Gretchen Vaughn; Jessica Trotter; Hector Monforte; David Lindsay; Elie Haddad; Michael D Keller; Benjamin R Oshrine; Jennifer W Leiding
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.